ACELYRIN INC (SLRN)
US00445A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to SLRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 102.08% above the current price.
SLRN was analyzed by 13 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SLRN.
In the previous month the buy percentage consensus was at a similar level.
SLRN was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-19 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-08 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-05-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-13 | Wells Fargo | Initiate | Equal-Weight |
| 2023-12-08 | Citigroup | Initiate | Neutral |
| 2023-11-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-28 | Jefferies | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-05 | HC Wainwright & Co. | Initiate | Buy |
| 2023-06-21 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-30 | TD Cowen | Initiate | Outperform |
| 2023-05-30 | Morgan Stanley | Initiate | Overweight |
| 2023-05-30 | Piper Sandler | Initiate | Overweight |
| 2023-05-30 | Jefferies | Initiate | Buy |